Solicitation of Nominations for Appointment to the Advisory Committee on Breast Cancer in Young Women (ACBCYW), 67751-67752 [2023-21568]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 189 / Monday, October 2, 2023 / Notices
Docket: For access to the docket to
read background documents or
comments received, go to https://
www.regulations.gov and search for
‘‘EEOC–2023–0005’’ or ‘‘RIN 3046–
ZA02.’’ The received comments also
will be available for review at the
Commission’s library, 131 M Street NE,
Suite 4NW08R, Washington, DC 20507,
between the hours of 9:30 a.m. and 5:00
p.m., from November 1, 2023 until the
Commission publishes the guidance in
final form. You must make an
appointment with library staff to review
the comments in the Commission’s
library.
FOR FURTHER INFORMATION CONTACT:
Lynn Davenport, Assistant Legal
Counsel, lynn.davenport@eeoc.gov;
Office of Legal Counsel, 202–856–7072
(voice), 1–800–669–6820 (TTY).
SUPPLEMENTARY INFORMATION:
Background
The EEOC is seeking public
comments on all aspects of its proposed
‘‘Enforcement Guidance on Harassment
in the Workplace’’ (proposed guidance)
pursuant to 29 CFR part 1695. The
proposed guidance presents a legal
analysis of standards for harassment and
employer liability applicable to claims
of harassment under the equal
employment opportunity statutes
enforced by the Commission. The
Commission posted and requested
public input on a proposed guidance on
workplace harassment in January 2017,
which was not finalized.
The contents of the final guidance
document will not have the force and
effect of law and are not meant to bind
the public in any way. The document is
intended only to provide clarity to the
public regarding Commission policies
and existing requirements under the
law. The standards discussed under
EEOC-enforced laws will not necessarily
apply to allegations of unlawful
harassment under other Federal laws or
under State or local laws.
For the Commission:
Charlotte A. Burrows,
Chair.
[FR Doc. 2023–21644 Filed 9–29–23; 8:45 am]
lotter on DSK11XQN23PROD with NOTICES1
BILLING CODE 6570–01–P
FARM CREDIT SYSTEM INSURANCE
CORPORATION
Board of Directors Meeting
Notice of the forthcoming
regular meeting of the Board of Directors
of the Farm Credit System Insurance
Corporation (FCSIC), is hereby given in
SUMMARY:
VerDate Sep<11>2014
18:41 Sep 29, 2023
Jkt 262001
accordance with the provisions of the
Bylaws of the FCSIC.
DATES: 10 a.m., Wednesday, October 11,
2023.
ADDRESSES: You may observe the open
portions of this meeting in person at
1501 Farm Credit Drive, McLean,
Virginia 22102–5090, or virtually. If you
would like to virtually attend, at least 24
hours in advance, visit FCSIC.gov, select
‘‘News & Events,’’ then select ‘‘Board
Meetings.’’ From there, access the
linked ‘‘Instructions for board meeting
visitors’’ and complete the described
registration process.
FOR FURTHER INFORMATION CONTACT: If
you need more information or assistance
for accessibility reasons, or have
questions, contact Ashley Waldron,
Secretary to the Board. Telephone: 703–
883–4009. TTY: 703–883–4056.
SUPPLEMENTARY INFORMATION: Parts of
this meeting will be open to the public.
The rest of the meeting will be closed
to the public. The following matters will
be considered:
Portions Open to the Public
• Approval of Minutes for July 12, 2023
• Quarterly FCSIC Financial Reports
• Quarterly Report on Insured
Obligations
• Quarterly Report on Annual
Performance Plan
• Annual Performance Plan
• Budget 2024–2025
Portions Closed to the Public
• Confidential Report on Insurance Risk
67751
The public portions of the
applications listed below, as well as
other related filings required by the
Board, if any, are available for
immediate inspection at the Federal
Reserve Bank(s) indicated below and at
the offices of the Board of Governors.
This information may also be obtained
on an expedited basis, upon request, by
contacting the appropriate Federal
Reserve Bank and from the Board’s
Freedom of Information Office at
https://www.federalreserve.gov/foia/
request.htm. Interested persons may
express their views in writing on the
question whether the proposal complies
with the standards of section 4 of the
BHC Act.
Unless otherwise noted, comments
regarding the applications must be
received at the Reserve Bank indicated
or the offices of the Board of Governors,
Ann E. Misback, Secretary of the Board,
20th Street and Constitution Avenue
NW, Washington DC 20551–0001, not
later than October 17, 2023.
A. Federal Reserve Bank of New York
(Ivan J. Hurwitz, Head of Bank
Applications) 33 Liberty Street, New
York, New York 10045–0001. Comments
can also be sent electronically to
comments.applications@ny.frb.org:
1. The Goldman Sachs Group, Inc.,
New York, New York; to engage in
community development activities
pursuant to section 225.28(b)(12) of the
Board’s Regulation Y.
Ashley Waldron,
Secretary to the Board.
Board of Governors of the Federal Reserve
System.
Michele Taylor Fennell,
Deputy Associate Secretary of the Board.
[FR Doc. 2023–21681 Filed 9–29–23; 8:45 am]
[FR Doc. 2023–21737 Filed 9–29–23; 8:45 am]
BILLING CODE 6705–01–P
BILLING CODE P
FEDERAL RESERVE SYSTEM
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Notice of Proposals To Engage in or
To Acquire Companies Engaged in
Permissible Nonbanking Activities
The companies listed in this notice
have given notice under section 4 of the
Bank Holding Company Act (12 U.S.C.
1843) (BHC Act) and Regulation Y, (12
CFR part 225) to engage de novo, or to
acquire or control voting securities or
assets of a company, including the
companies listed below, that engages
either directly or through a subsidiary or
other company, in a nonbanking activity
that is listed in § 225.28 of Regulation Y
(12 CFR 225.28) or that the Board has
determined by Order to be closely
related to banking and permissible for
bank holding companies. Unless
otherwise noted, these activities will be
conducted throughout the United States.
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
Centers for Disease Control and
Prevention
Solicitation of Nominations for
Appointment to the Advisory
Committee on Breast Cancer in Young
Women (ACBCYW)
ACTION:
Notice.
The Centers for Disease
Control and Prevention (CDC) is seeking
nominations for membership on the
ACBCYW. The ACBCYW consists of 15
experts in fields associated with breast
cancer, disease prevention, early
detection, diagnosis, public health,
social marketing, genetic screening and
counseling, treatment, rehabilitation,
palliative care, and survivorship in
SUMMARY:
E:\FR\FM\02OCN1.SGM
02OCN1
lotter on DSK11XQN23PROD with NOTICES1
67752
Federal Register / Vol. 88, No. 189 / Monday, October 2, 2023 / Notices
young women, or in related disciplines
with a specific focus on young women.
DATES: Nominations for membership on
the ACBCYW must be received no later
than November 10, 2023. Packages
received after this time will not be
considered for the current membership
cycle.
ADDRESSES: All nominations should be
mailed to Kimberly E. Smith, MBA,
MHA. c/o ACBCYW Secretariat, Centers
for Disease Control and Prevention,
3719 North Peachtree Road, Building
100, Chamblee, Georgia 30341 or
emailed (recommended) to acbcyw@
cdc.gov.
FOR FURTHER INFORMATION CONTACT:
Kimberly E. Smith, MBA, MHA,
Designated Federal Officer, National
Center for Chronic Disease Prevention
and Health Promotion, CDC, 4770
Buford Highway NE, Mailstop S107–4,
Atlanta, Georgia 30341, Telephone:
(404) 498–0073; acbcyw@cdc.gov.
SUPPLEMENTARY INFORMATION:
Nominations are being sought for
individuals who have expertise and
qualifications necessary to contribute to
the accomplishments of the committee’s
objectives. Nominees will be selected
based on expertise in the fields of breast
health, breast cancer, disease prevention
and risk reduction, survivorship
(including metastatic breast cancer),
hereditary breast and ovarian cancer
(HBOC), or in related disciplines with a
specific focus on young women. Persons
with personal experience with early
onset breast cancer are also eligible to
apply. This includes but may not be
limited to breast cancer survivors <45
years of age and caregivers of said
persons. Federal employees will not be
considered for membership. Members
may be invited to serve up to four-year
terms. Selection of members is based on
candidates’ qualifications to contribute
to the accomplishment of ACBCYW
objectives (https://www.cdc.gov/maso/
facm/facmacbcyw.html).
The U.S. Department of Health and
Human Services policy stipulates that
committee membership be balanced in
terms of points of view represented, and
the committee’s function. Appointments
shall be made without discrimination
on the basis of age, race, ethnicity,
gender, sexual orientation, gender
identity, HIV status, disability, and
cultural, religious, or socioeconomic
status. Nominees must be U.S. citizens
and cannot be full-time employees of
the U.S. Government. Current
participation on federal workgroups or
prior experience serving on a federal
advisory committee does not disqualify
a candidate; however, HHS policy is to
avoid excessive individual service on
VerDate Sep<11>2014
18:41 Sep 29, 2023
Jkt 262001
advisory committees and multiple
committee memberships. Committee
members are Special Government
Employees, requiring the filing of
financial disclosure reports at the
beginning and annually during their
terms. CDC reviews potential candidates
for ACBCYW membership each year and
provides a slate of nominees for
consideration to the Secretary of HHS
for final selection. HHS notifies selected
candidates of their appointment near
the start of the term in November 2024,
or as soon as the HHS selection process
is completed. Note that the need for
different expertise varies from year to
year and a candidate who is not selected
in one year may be reconsidered in a
subsequent year. SGE nominees must be
U.S. citizens and cannot be full-time
employees of the U.S. Government.
Candidates should submit the following
items:
D Current curriculum vitae, including
complete contact information
(telephone numbers, mailing address,
email address).
D At least one letter of
recommendation from person(s) not
employed by the U.S. Department of
Health and Human Services.
(Candidates may submit letter(s) from
current HHS employees if they wish,
but at least one letter must be submitted
by a person not employed by an HHS
agency (e.g., CDC, NIH, FDA, etc.).
D A short biography (150 words or
less).
Nominations may be submitted by the
candidate him- or herself, or by the
person/organization recommending the
candidate.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2023–21568 Filed 9–29–23; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2023–0076]
Advisory Committee on Immunization
Practices (ACIP); Amended Notice of
Meeting
Centers for Disease Control and
Prevention, Department of Health and
Human Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
Advisory Committee on Immunization
Practices (ACIP). This meeting is open
to the public.
FOR FURTHER INFORMATION CONTACT:
Stephanie Thomas, Committee
Management Specialist, Advisory
Committee on Immunization Practices,
National Center for Immunization and
Respiratory Diseases, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, Mailstop H24–8,
Atlanta, Georgia 30329–4027.
Telephone: (404) 639–8836; Email:
ACIP@cdc.gov.
SUPPLEMENTARY INFORMATION: Notice is
hereby given of a change in the meeting
of the Advisory Committee on
Immunization Practices (ACIP);
September 22, 2023, 10 a.m. to 5 p.m.,
EDT (times subject to change, see the
ACIP website for updates: https://
www.cdc.gov/vaccines/acip/index.
html), in the original Federal Register
notice.
Notice of the virtual meeting was
published in the Federal Register on
September 6, 2023, Volume 88, Number
171, pages 60945–60946.
Notice of the virtual meeting is being
amended to add an additional agenda
item in the matters to be considered,
which should read as follows:
Matters to be Considered: The agenda
will include discussions of maternal
respiratory syncytial virus (RSV)
vaccine, child/adolescent immunization
schedules and adult immunization
schedule. A recommendation vote for
maternal RSV vaccine is scheduled. A
Vaccines for Children vote is scheduled
for maternal RSV vaccine. Agenda items
are subject to change as priorities
dictate. For more information on the
meeting agenda, visit https://
www.cdc.gov/vaccines/acip/meetings/
index.html.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
SUMMARY:
E:\FR\FM\02OCN1.SGM
02OCN1
]]>Agencies
[Federal Register Volume 88, Number 189 (Monday, October 2, 2023)]
[Notices]
[Pages 67751-67752]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-21568]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Solicitation of Nominations for Appointment to the Advisory
Committee on Breast Cancer in Young Women (ACBCYW)
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC) is
seeking nominations for membership on the ACBCYW. The ACBCYW consists
of 15 experts in fields associated with breast cancer, disease
prevention, early detection, diagnosis, public health, social
marketing, genetic screening and counseling, treatment, rehabilitation,
palliative care, and survivorship in
[[Page 67752]]
young women, or in related disciplines with a specific focus on young
women.
DATES: Nominations for membership on the ACBCYW must be received no
later than November 10, 2023. Packages received after this time will
not be considered for the current membership cycle.
ADDRESSES: All nominations should be mailed to Kimberly E. Smith, MBA,
MHA. c/o ACBCYW Secretariat, Centers for Disease Control and
Prevention, 3719 North Peachtree Road, Building 100, Chamblee, Georgia
30341 or emailed (recommended) to [email protected].
FOR FURTHER INFORMATION CONTACT: Kimberly E. Smith, MBA, MHA,
Designated Federal Officer, National Center for Chronic Disease
Prevention and Health Promotion, CDC, 4770 Buford Highway NE, Mailstop
S107-4, Atlanta, Georgia 30341, Telephone: (404) 498-0073;
[email protected].
SUPPLEMENTARY INFORMATION: Nominations are being sought for individuals
who have expertise and qualifications necessary to contribute to the
accomplishments of the committee's objectives. Nominees will be
selected based on expertise in the fields of breast health, breast
cancer, disease prevention and risk reduction, survivorship (including
metastatic breast cancer), hereditary breast and ovarian cancer (HBOC),
or in related disciplines with a specific focus on young women. Persons
with personal experience with early onset breast cancer are also
eligible to apply. This includes but may not be limited to breast
cancer survivors <45 years of age and caregivers of said persons.
Federal employees will not be considered for membership. Members may be
invited to serve up to four-year terms. Selection of members is based
on candidates' qualifications to contribute to the accomplishment of
ACBCYW objectives (https://www.cdc.gov/maso/facm/facmacbcyw.html).
The U.S. Department of Health and Human Services policy stipulates
that committee membership be balanced in terms of points of view
represented, and the committee's function. Appointments shall be made
without discrimination on the basis of age, race, ethnicity, gender,
sexual orientation, gender identity, HIV status, disability, and
cultural, religious, or socioeconomic status. Nominees must be U.S.
citizens and cannot be full-time employees of the U.S. Government.
Current participation on federal workgroups or prior experience serving
on a federal advisory committee does not disqualify a candidate;
however, HHS policy is to avoid excessive individual service on
advisory committees and multiple committee memberships. Committee
members are Special Government Employees, requiring the filing of
financial disclosure reports at the beginning and annually during their
terms. CDC reviews potential candidates for ACBCYW membership each year
and provides a slate of nominees for consideration to the Secretary of
HHS for final selection. HHS notifies selected candidates of their
appointment near the start of the term in November 2024, or as soon as
the HHS selection process is completed. Note that the need for
different expertise varies from year to year and a candidate who is not
selected in one year may be reconsidered in a subsequent year. SGE
nominees must be U.S. citizens and cannot be full-time employees of the
U.S. Government. Candidates should submit the following items:
[ssquf] Current curriculum vitae, including complete contact
information (telephone numbers, mailing address, email address).
[ssquf] At least one letter of recommendation from person(s) not
employed by the U.S. Department of Health and Human Services.
(Candidates may submit letter(s) from current HHS employees if they
wish, but at least one letter must be submitted by a person not
employed by an HHS agency (e.g., CDC, NIH, FDA, etc.).
[ssquf] A short biography (150 words or less).
Nominations may be submitted by the candidate him- or herself, or
by the person/organization recommending the candidate.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-21568 Filed 9-29-23; 8:45 am]
BILLING CODE 4163-18-P
